Want to see QNRX full AI Analyst Report?
Quoin Pharmaceuticals (QNRX) Income Statement
Quoin Pharmaceuticals Income Statement
Last quarter (Q2 2026), Quoin Pharmaceuticals's total revenue was $0.00. In Q2, Quoin Pharmaceuticals's net income was $-5.46M. See Quoin Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 16.29M | $ 9.53M | $ 9.38M | $ 9.26M | $ 6.06M | |
| Depreciation and Amortization | $ 100.00K | $ 100.00K | $ 103.71K | $ 104.04K | $ 104.04K |
| $ -15.70M | $ -8.86M | $ -8.58M | $ -8.56M | $ -20.27M | |
| $ -16.29M | $ -9.53M | $ -9.38M | $ -9.26M | $ -6.06M | |
| $ 486.06K | $ 565.99K | $ 691.93K | $ -123.79K | $ -15.40M | |
| $ -15.80M | $ -8.96M | $ -8.69M | $ -9.38M | $ -21.46M | |
| $ -15.80M | $ -8.96M | $ -8.69M | $ -9.38M | $ -21.46M | |
| Per Share Metrics | |||||
| Basic EPS | $ -10.63 | $ -2352.81 | $ -11781.00 | $ -11.42 | $ -2490.26 |
| Diluted EPS | $ -10.63 | $ -2352.81 | $ -11781.00 | $ -11.42 | $ -2490.26 |
| Weighted Average Shares Outstanding | 1.50M | 3.83K | 735 | 823.71K | 8.62K |
| Weighted Average Shares Outstanding (Diluted) | 1.50M | 3.83K | 735 | 823.71K | 8.62K |
Currency in USD